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T cell subsets bearing Fe-receptors for either IgG (Te) 
or IgM (TM), and suppressor cell activity of peripheral 
blood mononuclear cells on in vitro lymphoproliferative 
responses were studied in patients with untreated pso-
riasis. The proportions ofTe and TM cells were unmodi-
fied in 15 patients compared to 15 control subjects stud-
ied in parallel experiments. The concanavalin A -induced 
suppressor cell activity, as well as the spontaneous sup-
pressor cell function of in vitro short-lived adherent 
cells, were in the normal range for 7 out of 8 psoriatic 
patients investigated. The data argue against the possi-
bility that a generalized suppressor cell defect occurs in 
psoriasis. 
Following th e first report of a T cell defect in untreated 
patients with psoriasis [1-3], Guilhou et al have proposed an 
hypothesis of t h e path ogenesis of cutaneous psoriasis, by relat-
ing the immunological abnormalit ies to t h e oth er features of 
the disease, such as t h e epidermal proliferation, cyclic nucleo-
tide and prostaglandin imbalance, and the extrinsic factors [4]. 
According to th e different aspects of the T cell defect, it was 
suggested [5] t hat a n impairment of T suppressor cells could 
explain the abnormal increase of IgA a nd IgE [6], and the 
occurence of a utoantibodies during the disease [3,6]. 
The regulation of the immune response requi.res the interplay 
of effector, h elper, and suppressor mechanisms, which are sus-
tained by various cell populations, including B cells, T cells, 
and adh erent cells. Among T lymphocytes, subpopulations of 
cells with receptors for the Fc part of eith er IgG (Te ) or IgM 
(T[v1) have been demonstrated by rosetting techniques [7]. T c 
cells have been shown to exert suppressor function and TM cells 
helper activity [8]. Furthermore, recent adva nces have intro-
duced several suppressor cell assays in man [8-11] to study the 
suppressor cell activity demonstrated on various targets such 
as mitogen responsiveness or B cell differentiation. 
To investigate the hypoth esis of a T suppressor cell defect in 
psoriatic patients, we studied T cell subsets and suppressor cell 
activity in psoriatic and normal peripheral blood. The suppres-
sor cell assays h eJ'ein i.nvestigated concerned both T and ad-
herent suppressor cells, acting on lymphoproliferative responses 
to polyclonal mitogens. 
MATERIALS AND METHODS 
Patients 
Fifteen patients with psoriasis were studied. They were 10 males and 
5 females (mean age = 42 yr; range = 16-66 yr). The duration of the 
disease was from 6 mo to 20 yr. Of these patients, 3 had few lesions, 7 
had numerous disseminated lesions, and 5 had generalized psoriasis 
(more than 50% body involvement). An arthropathy was noted in 2 
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cases. None of these patients received any topical or systemic immu-
nodepressive therapy for 6 mo prior to this study. 
The control group included 15 sex and age-matched healthy volun-
teers. 
Isolation of Mononuclear Cells 
Peripheral blood mononuclear cells (PBMC) were obtained from 
heparinized peripheral blood, from one psoriatic patient and one control 
subject in the same experiment, by centrifugation (400 g, 30 min, 20°C) 
on a Ficoll-Hypaque gradient. The interphase cells were collected and 
then washed three times with RPMI 1640 culture medium supple-
mented with 5% fetal calf serum (FCS). 
Purification of T Cells 
T lymphocytes were separated by rosetting with neuraminidase-
treated sheep red blood cells (SRBC) followed by gradient centrifuga-
tion, as al.ready reported [13]. The SRBC coated on 'I' cells were lysed 
by treatment with 0.83% NH .. CI. 
Detection of Tc and TM Cells 
T c and 'I'M cells were identified by rosette formation. Ox red blood 
cell-antibody (EA) complexes were prepared by mixing 100 ,ul of ox 
erythrocytes and an equal volume of sUbagglutinating amounts of either 
rabbit purified IgG antibody (OxEAc) or rabbit purified IgM antibody 
(OxEAM). After 30 min incubation at 37°C and 3 washes, the pellet was 
resuspended to a concentration of 0.2%. PW'ified 'I' cells in phosphate 
buffer saline-bovine serum albumin solution were mixed with OxEAr. 
or OxEAM complexes. The tubes were centrifuged at 200 g for 5 min at 
4°C, and then incubated at 4 °C for 60 min. After gentle resuspension, 
the percentage of rosette-forming cells was determined by counting 200 
lymphocytes. 'I' cells examined for OxEAM-rosette formation had been 
incubated overnight at 37°C in RPMI 1640 medium supplemented by 
15% FCS. Tests for T c cells were done by using freshly prepru'ed 'I' 
cells. 
Can A ·induced Suppressor Cell Assay 
In this suppressor ' cell assay, suppressor 'I' cells were first generated 
by concanavalin A (Con A) during a 48 hr culture period. The suppres-
sor function was then tested on the lymphoproliferative response of 
fresh autologous responder PBMC to polyclonal mi togens. The method 
derived from that reported by Shou et aI [10,13]' In a first cul ture 
period, PBMC were incubated with or without 50 f1g/ ml of Con A for 
48 lu at incubation, the unstimulated cells and the Con A-activated 
cells were hru'vested sepru'ately, washed with 30 mM a-methyl-manno-
side, treated with mitomycin C (25 ,ug/ ml, 20 min, 37°C), and washed 
again. Two cell suspensions were thus used: a Con A-activated mito-
myCin-treated cell suspension (CM-cells), and an unstimulated mito-
mycin-treated cell suspension (M-ceUs) . CM-cells and M-ceLls were 
respectively l'eferred to as suppressor and control cells. In a second 
cultUl'e period, fresh PBMC obtained from the same subject were 
cultured in microplates (lOr. cells/ well) . In addition to unstimulated 
controls, lymphocyte cultures were stimulated with the following mi· 
togens: phytohemagglutinin (PHA-P) and Con A. These second cul-
tures were added with 5 x 10" M- and CM-cells from the fU'st cul ture. 
After 72 hr incubation, the 3H-thymidine incorporation was determined 
by liquid scintillation counting. The data were expressed as mean 
disintegrations per minute (dpm) fo r four replicates ± sem. A t.dpm 
was calcu lated by subtracting dpm of unstimulated cultures from dpm 
of stimulated cultures. T he degree of supression was evaluated accord-
ing to the formu la: % suppression = 1 - (t.dpm of cultures added with 
CM-cells/t.dpm of cu ltures added with M-cells) X 100. 
Co· culture Experiments 
In an attempt to determine both the generation of, and the response 
to a suppressor cell activity, allogeneic cocultures were performed 
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between control and psoriasis PEMC. At th e same time, M- a nd CM-
cells were prepared with PEMC from one normal donor and one patient 
with psoriasis, as indicated a bove. Forty-eight hours later, fresh PEMC 
were obtained again from the same subjects and cultured with the 
fo llowing combinations: (a) normal PBMC added with M- or CM-
autologous cells; (b) psoriatic PEMC added with M- or CM-autologous 
cells; (c) psoriatic PEMC added with M- or CM-cells from a normal 
donor; (d) normal PEMC added with M- or CM-cells from a psoriatic 
patien t. T he resul ts were expressed as percentage of suppression. 
Spontaneous Suppressor Cell Assay 
This system was based on the observation of Dutton [14] and 
Eresnihan and J asin [15], showing that spontaneous suppressor cells 
were short-lived in vitro. The method was previously reported [16]. 
Briefly, PBMC were cultured separately in two microplates (10" cells/ 
well). In one plate, PHA and Con A at subopt imal doses (1 and 5 p.g/ 
ml) were added to these fresh cells immediately (to). The second plate, 
containing PEMC in culture medium alone (RPMI 1640 added wit h 
15% pooled inactivated human AB serum), was incubated for 24 hI' at 
37°C, before the addition of the same mitogen concentrations (t24) . 
The two plates were incubated for 72 hr after the addition of mitogens. 
The 3H-thymidine incorporation was determined as above. The sup-
pressor activity was demonstrated by the enhancemen t of proliferative 
responses to mitogens of the 24 hr-preincubated PEM C, and calculated 
according to: ~24/ M = ~dpm of 24hr-preincubated cells! tldpm of fresh 
cells . 
RESULTS 
T G and TM Cell Proportions in Psoriatic Patients 
As no statistical difference appeared in total lymphocyte 
counts between psoriatic patients and control subjects, the 
results (Table I) were expressed as percentages of T cells 
bearing Fc-receptors for either IgG or IgM. In this small patient 
group, the total proportion of T cells detected by E-rosette-
forming cells was significantly decreased, as previously r eported 
in larger groups of psoriatic patients [4]. However, the propor-
tions of T G and TM lymphocytes were identical to those of 
control subjects. The ratio of TM cells to T G cells was unmodi-
fied. 
Con A-induced Suppressor Cell Activity in Psoriasis 
In 25 previous experiments [13] it has been shown that Con 
A-activated PBMC from normal donors were able to signifi-
cantly suppress the mitogenic response to PHA (mean % sup-
pression = 46.5 ± 6.3 (sem)), and to Con A (mean % suppTession 
= ,61.4 ± 5.9 (sem)) . These results were obtained in cultures 
stimulated by 5 Ilg/rnl of both mitogens. Eight parallel experi-
ments were performed by using psoriatic and normal PBMC. 
The results (Table II) showed that only one psoriatic patient 
(case n °2) had a defect of his suppressor activity versus both 
PHA and Con A responses. The other 7 patients had Con A-
induced suppressor cell functions (mean % suppression of PHA 
responsiveness = 51.4 ± 9.6; mean % suppression of Con A 
responsiveness= 63.2 ± 4.3) Ul the range of the normal subjects 
(mean % suppression of PHA responsiveness = 54.1 ± 10.8; 
mean % suppression of Con A responsiveness = 67.6 ± 5.3). 
Coculture experiments were performed between PBMC from 
TABLE I. Proportions of TM and To cells in psoriatic peripheral 
blood (1 5 parallel exjJeriments) 
Total 
'I'M cells T c cells Ratio T cells TM / 'T" 
Psoriatic patients 62.8 ± 7.1" 41.1 ± 15.6 19.8 ± 7.6 2.3 ± 1.2 
Controls 74.2 ± 8.1 40.5 ± 12.2 20.1 ± 8.8 2.0 ± 0.4 
t-tests on paired p < 0.01 h ns ns ns 
values 
" Resul ts expressed as mean percentages '± sd. 
b p-value from Student's I-test calculated on each paired value ob-
tained in a control subject and a psoriatic patient in the same experi-
m~t . 
ns = not significant. 
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TABLE II. R esults of Con A·induced suppressor cell assay and of 
coculture experiments between psoriatic and control cells 
Source of M- and Responder cells % supptession " 
N° CM-cells from the in the second 
first culture!1 culture PHA Con A 
1 Control C Control 74 .2 72.2 
Psoriasis" Psoriasis 68.2 64.2 
Control Psoriasis 61.0 42.6 
Psoriasi3 Control 58.6 60.1 
2 Control Control 57.9 74.5 
Psoriasis Psoriasis 
...M 
.JU 
Control Psoriasis 15.1 ~ 
Psoriasis Control 40.8 44.2 
3 Control Control 45.4 67.1 
Psoriasis Psoriasis 43.2 65.9 
Control Psoriasis 53.5 46.9 
Psoriasis Control 58.9 43.5 
4 Control Con trol 41.6 62.4 
Psoriasis Psoriasis 48.1 66.4 
Control Psoriasis 45.5 61.8 
Psoriasis Control 49.7 60.9 
5 Control Control 45.1 70.8 
Psoriasis P soriasis 41.0 60.2 
Control Psoriasis 42.3 61.7 
Psoriasis Control 44.2 59.3 
6 Control Control 62.3 68.9 
Psoriasis Psoriasis 60.3 67.6 
Control Psoriasis 46.2 63.8 
Psoriasis Control 42.9 56.8 
7 Control Control 56.0 58.2 
Psoriasis Psoriasis 49.9 55.2 
Control P soriasis 60.1 57.3 
Psoriasis Control 43.9 41.5 
8 Control Control 50.3 66.4 
Psoriasis Psoriasis 49.1 62.7 
Control Psorias is 56.3 54.0 
Psoriasis Control 60.1 56.4 
" M-cells al'e unstimulated mitomycine-treated PEMC; CM-cells are 
Con A-activated mi tomycin -treated s\lppressol' PEMC. 
/, Percentage of suppression of the lymphoproliferative responses to 
10 p.g/ ml PHA and 10 p.g/ml Con A, and calculated as indicated in 
Materia l and Methods. 
" Cells from a normal donor. 
d Cells from a patient with psoriasis. 
the same 8 psoriatic patients and 8 control subjects. The final 
results, expressed as percentage of suppression of PHA and Con 
A responsiveness, are indicated in Table II. The 7 patients 
having normal suppressor cell functions, were also able to 
suppress the lymphoproliferative responses of PBMC from 
normal donors. Their mitogen responses were also decreased 
by Con A-induced suppressor cells from normal SUbjects. The 
PBMC from the only patient (case n 02) with a suppressor cell 
defect were able to exert a suppressor effect on normal PBMC. 
In contrast, th e responses of his PBMC to mitogens were not 
suppressed by Con A-induced suppl'eSsOl' cells from a normal 
donor. Thus, this only patient presented a defect of PBMC 
sensitivity to suppressor signals provided by his own Con A-
induced suppressor cells and by normal suppressor cells. 
Spontaneous Suppressor Cell A ctivity in Psoriasis 
We previously demonstrated (16] in 20 experiments with 
normal PBMC, an enhancement of the proliferative responses 
when mitogens were added to 24hr-preincubated cells. It was 
demonstrated that this phenomenon was due to the loss of 
functional properties of spontaneous adherent suppressor cells 
during the 24hr-preincubation period [7]. Such a spontaneous 
suppressor cell activity was found to be in the normal range in 
8 patients with psoriasis (mean ratio il24/ M = 6.4 ± 0.5) 
compared to 8 normal donors studied in parallel experiment 
(mean ratio il24/ilO = 6.6 ± 0.3) in which PBMC were stimu-
lated with 1 ,lLg/ rnl of Con A (Table III). Similar data were 
obtained by using 1 Ilg/m1 of PHA. 
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TABLE III. R esults of the spontaneous suppressor cell assay in 8 
parallel experiments with mononuclear cells from psoriatic patients 
and control subjects stimulated by 1 p.g/ ml of Can A 
Source of "H-thymidine incorporation of 
mononuclear 24hl·-preincubated Ratio t.24 / t.O" 
cells Fresh cells ce lls 
1. Control 1167" 7468 6.4 
Psoriasis 965 5790 6.0 
2. Control 1980 14256 7.2 
Psoriasis 1254 8527 6.8 
3. Control 1356 8678 6.4 
Psoriasis 1548 9443 6.1 
4. Control 1107 7527 6.8 
Psoriasis 992 6249 6.3 
5. Con trol 1392 9048 6.5 
Psoriasis 1406 10123 7.2 
6. Control 1985 13498 6.8 
Psoriasis 1687 9953 5.9 
, 7. Control 2003 14221 7.1 
Psoriasis 1359 9377 6.9 
8. Control 1683 10603 6.3 
Psoriasis 1580 9322 5.9 
a The rat io Cl24 / ClO was calculated as indicated in Material and 
Methods. 
b The results are expressed as Cldpm from 10" cells stimulated by 1 
M/ml of concanavalin A. 
DISCUSSION 
T h e data herein reported showed no major defect of sup-
pressor cell subsets and functions in cutaneous psoriasis. 
As we previously reported in preliminary experiments [17], 
the proportions ofTM and T G cells were unmodified in untreated 
psoriatic patients. Such subsets were claimed to exert helper 
(TM ) or suppressor (TG) cell function on B lymphocyte differ-
entiation [8]. However, a so clear-cut relationship was recently 
discussed [18 ], and raised the question of exact correlation 
between membrane markers and lymphocyte functions. 
Suppressor functions of PBMC have been very recently 
investigated in psoriasis [19,20]. Sauder et al [19], by using the 
Con A-induced suppressor system, have shown a reduced sup-
pressor effect on mixed lymphocyte reaction in 10 psoriatic 
patients. Hunyadi et al [20], by using the same spontaneous 
suppressor cell system as in the present study, have demon-
strated a decreased mean value of suppressor activity in 25 
patients. 
The discrepancies between these results and OUl" data could 
depend on various technical conditions and patient selection. It 
must be stressed out that in Sauder's study, all patients had 
greater than 50% body involvement, whereas in our study only 
3/8 patients had similar clinical extent. The only patient with 
a suppressor cell defect (case n 02) had an erythrodermic pso-
riasis. According to the important intrinsic variations in such in 
vitro models, pai.red studies must be performed in the same 
experiment with a psoriatic patient and a control subject. The 
comparison of mean suppression in a group, as done in the two 
other studies, could be less valid than individual values. More-
over, the results obtained with a given suppressor cell system 
cannot be extended to an other one, and do not necessarily 
account for a general and/or transient suppressor cell defect of 
the immune response. For instance, the suppression of B cell 
differentiation or the antigen-specific suppressor cells have not 
been yet studied in psoriasis. However, the concordant lack of 
suppressor cell deficiency in this disease was herein demon-
strated by three different in vitro assays. 
The humoral immunological features described in psoriasis 
[3,6] could suggest a defect of the immune response regulation 
[4,5]. But, these humoral abnormalities are far from the B cell 
hyperactivity reported in systemic lupus erythematosus [21], a 
disease clearly associated with a T suppressor cell defect 
[15,22,23]. 
The pathogenesis of psoriasis must be re-evaluated according 
to th ese new data. The immunological abnOl-malities of the 
disease would not be related to a primary suppressor cell defect, 
but could be secondary linked to the extent of psoriatic lesions. 
However, an impai.rment of other aspects of the immune re-
sponse regulation, such as direct polyclonal activation of B cells 
or antigen-specific T cell regulator functions, cannot be ruled 
ou t and needs fUl"ther investigations. 
We are very gl'ateful to the excellent technical assistance of Mrs. 
Line Lioure· and Christiane Cros. 
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